Trials / Unknown
UnknownNCT04530461
Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- faida agili · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An observational study aiming to assess the serological profile of SARS-Cov2 patients with systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, inflammatory myopathies, Behçet's disease, Rheumatoid arthritis and Spondyloarthritis
Detailed description
The study is a prospective, observational, multicenter clinical trial to be conducted in the internal medicine, rheumatology and virology departments of Military Hospital of Tunis. After obtaining informed consent from the patient, the investigator will perform an inclusion visit made of a patient interview and performing blood sample to search for IgG and anti-SARS IgM CoV2. Patients with IgM-like antibodies will have an RT-PCR test for active infection. If the study participants will be diagnosed with COVID-19 positive during the study period, the attending physician is entitled to decide on their management based on the severity of the clinical status.
Conditions
- SARS-CoV Infection
- Systemic Disease
- Systemic Lupus Erythematosus
- Sjogren's Syndrome
- Sarcoidosis
- Inflammatory Myopathy
- Behçet Disease
- Rheumatoid Arthritis
- Spondyloarthritis
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Serological test | Positive serological test of SARS Cov2 |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2020-11-30
- Completion
- 2021-01-31
- First posted
- 2020-08-28
- Last updated
- 2020-09-22
Locations
1 site across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT04530461. Inclusion in this directory is not an endorsement.